Researchers report that gender-affirming hormone therapy improves both physical and psychological satisfaction for those who use the treatment to attain their true gender identity.
Estrogen sets up physical differences in the brains of males and females during development, a new study reports.
Certain reproductive events, such as early menstruation, early menopause, and hysterectomy were linked to an increased risk of a woman developing dementia later in life. Women who experienced pregnancy or who entered into menopause later were at a lower risk for dementia.
Social support, in addition to access to gender-affirming hormones and puberty blockers, helps reduce depression and suicidal ideation in young transgender people.
Prolactin, a hormone responsible for milk production in mothers, reduces a mother's investment in aggressive behaviors and helps to increase protective behaviors.
Irisin, a hormone secreted by muscles during exercise, improved cognitive function and lowered levels of inflammation in mouse models. The findings have implications for the development of treatments for Alzheimer's and other neurodegenerative diseases.
In mice, natural melatonin is linked to a pre-hibernation state, allowing for a slower metabolism and survival when food is scarce or the temperature is too cold.
Higher levels of the hunger hormone ghrelin predict a greater preference for smaller, immediate financial rewards over larger, delayed financial rewards.
Sex hormones play a crucial role in brain health, especially when it comes to the sex-based risk factors associated with dementia.
Exercise promotes the hypothalamus to release MOTS-c. Mitochondrial encoded MOTS-c interacts with the nuclear genome and regulates both cell metabolism and the stress response.
Menopausal women who frequently sunbathe have increased levels of gonadotropins and lower levels of estrogen than their peers who are not active sun worshipers. Low estrogen levels and higher levels of other hormones increase the risk for a number of health problems, including Alzheimer's disease.
A new study suggests COVID-19 may deplete testosterone levels in males. Findings reveal as testosterone decreased, the severity of coronavirus increased. Men who died from coronavirus infection had significantly lower mean testosterone than those who recovered. For those who were asymptomatic, 65.2% reported a loss in libido.
